A Study to Assess the Safety, Tolerability and How Single Ascending Doses of ABBV-859 Moves Through the Body of Healthy Adult Participants

Clinical trial NCT07736638 · RECRUITING

Trial details

NCT number: NCT07736638
Sponsor: AbbVie
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2026-07-28
Primary completion: 2027-02-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.